<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Benedetti E</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Neutropenic enterocolitis (NEC) is a life-threatening complication reported in patients with acute myeloid leukemia (AML) following chemotherapy (CHT). Intensive induction and consolidation CHT may damage intestinal mucosa leading to a NEC episode (NECe). NEC reported mortality may be up to 30-60%. Early US-guided bed-side diagnosis and prompt treatment may substantially improve the survival. An emerging worldwide concern is the intestinal colonization by multi-drug-resistant bacteria especially when patients are exposed to chemotherapy regimens potentially correlated to mucosal damage.&lt;h4>Methods&lt;/h4>In our study we prospectively enrolled all AML patients admitted in our leukemia unit to receive intensive induction and consolidation chemotherapy and experiencing chemo</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1272072</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10646482</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.</pubmed_title><pmcid>PMC10646482</pmcid><pubmed_authors>Bruno B</pubmed_authors><pubmed_authors>Giubbolini R</pubmed_authors><pubmed_authors>Ricchiuto V</pubmed_authors><pubmed_authors>Arena C</pubmed_authors><pubmed_authors>Stella SM</pubmed_authors><pubmed_authors>Neri E</pubmed_authors><pubmed_authors>Bramanti E</pubmed_authors><pubmed_authors>Pucci G</pubmed_authors><pubmed_authors>Susini MC</pubmed_authors><pubmed_authors>Galimberti S</pubmed_authors><pubmed_authors>Mavilia F</pubmed_authors><pubmed_authors>Mazzantini E</pubmed_authors><pubmed_authors>Traverso G</pubmed_authors><pubmed_authors>Cerri F</pubmed_authors><pubmed_authors>Benedetti E</pubmed_authors><pubmed_authors>De Simone L</pubmed_authors><pubmed_authors>Lippolis P</pubmed_authors><pubmed_authors>Capochiani E</pubmed_authors><pubmed_authors>Valentini K</pubmed_authors><pubmed_authors>Morganti R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.</name><description>&lt;h4>Introduction&lt;/h4>Neutropenic enterocolitis (NEC) is a life-threatening complication reported in patients with acute myeloid leukemia (AML) following chemotherapy (CHT). Intensive induction and consolidation CHT may damage intestinal mucosa leading to a NEC episode (NECe). NEC reported mortality may be up to 30-60%. Early US-guided bed-side diagnosis and prompt treatment may substantially improve the survival. An emerging worldwide concern is the intestinal colonization by multi-drug-resistant bacteria especially when patients are exposed to chemotherapy regimens potentially correlated to mucosal damage.&lt;h4>Methods&lt;/h4>In our study we prospectively enrolled all AML patients admitted in our leukemia unit to receive intensive induction and consolidation chemotherapy and experiencing chemo</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-26T21:15:39.77Z</modification><creation>2025-02-19T00:38:19.415Z</creation></dates><accession>S-EPMC10646482</accession><cross_references><pubmed>38023169</pubmed><doi>10.3389/fonc.2023.1272072</doi></cross_references></HashMap>